Shorts
0:35
Personalizing Communication About Emerging Alzheimer Disease Therapies
an hour ago
by
Betty Tijms, PhD(+1 more)
1:07
Fragile X Syndrome Day 2026: 3 Primary Domains of Symptoms
a day ago
by
Craig A. Erickson, MD(+1 more)
0:47
World Brain Day 2026: What is the Best Way to Preserve and Maintain Brain Health?
2 days ago
by
Jason A. Cohen, MD(+1 more)
0:44
AAIC 2026: Why Every “Shot on Goal” Matters in Alzheimer Disease Care
2 days ago
by
Louie Pasculli(+1 more)
1:41
SLEEP 2026: Designing Phase 3 Trials for Narcolepsy Type 1
3 days ago
by
Elena Koundourakis, PhD(+1 more)
1:13
SLEEP 2026: Unmet Needs in Pediatric Sleep Medicine
3 days ago
by
Carol Rosen, MD(+1 more)
0:41
AAIC 2026: Where Can Patients Learn About Emerging Alzheimer Disease Therapies?
4 days ago
by
Jeff Dage, PhD(+1 more)
0:58
SLEEP 2026: New Guidance on RLS Management
7 days ago
by
Michael Silber, MBChB(+1 more)
0:53
Symptom Overlap Between Multiple Sclerosis and NMOSD
7 days ago
by
Mitzi Joi Williams, MD
0:50
CMSC 2026: Questioning Targets in MS Treatment
8 days ago
by
Ahmed Obeidat, MD, PhD(+1 more)
1:15
CMSC 2026: Enhancing MS Clinical Trial Impact
8 days ago
by
Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC(+1 more)
0:40
AAIC 2026: Rethinking Patient-Centered Neurology Care Today
9 days ago
by
Mirnova Ceide, MD, MS(+1 more)
0:40
Expanding the Approach to AD Care Beyond Pharmacological Treatments
9 days ago
by
Elizabeth Rhodus, PhD, MS(+1 more)
0:58
RECAP: Neurology News Network - July 12th
12 days ago
by
Louie Pasculli
0:40
AAIC 2026: Characterizing Midlife Brain Health in Retired Soccer Players
12 days ago
by
Caleigh G. Lynch, MSc(+1 more)
1:00
The 2024 MS Diagnostic Criteria: More Than a Definition Update
14 days ago
by
Daniel Ontaneda, MD, PhD(+1 more)
0:35
Building a Path Toward Neuropathy Reversal
15 days ago
by
Brian Callaghan, MD, MS
1:02
Diagnosis Is Not the Same as Treatment in Multiple Sclerosis
16 days ago
by
Daniel Ontaneda, MD, PhD(+1 more)
1:46
How Biomarkers Can Help Clarify the MS Diagnostic Gray Zone
17 days ago
by
Daniel Ontaneda, MD, PhD(+1 more)
1:17
RECAP: Neurology News Network - July 4th
19 days ago
by
Louie Pasculli
0:56
Debunking Nerve Pain Myths
21 days ago
by
Mitzi Joi Williams, MD
2:00
Incorporating Biomarkers as Clinical End Points in Nerve Disorder Trials
22 days ago
by
Brett Morrison, MD, PhD
2:07
MicroRNAs Emerge as Promising Biomarkers for Diabetic Neuropathy
22 days ago
by
Brett Morrison, MD, PhD
1:39
RECAP: Neurology News Network - June 27th
24 days ago
by
Louie Pasculli
2:06
SLEEP 2026: Media Training Workshop on Sleep Science
a month ago
by
Julie Flygare, JD(+1 more)
1:03
ATMRD 2026: Understanding Demoralization in Parkinson Disease
a month ago
by
Indu Subramanian, MD(+1 more)
2:06
PNS 2026: Debate Between iPSC and Animal Models for Neuropathy Research
a month ago
by
Ahmet Hoke, MD, PhD
1:13
AHS 2026: Real-World INFUSE Trial of Eptinezumab in Migraine
a month ago
by
Amaal J. Starling, MD(+1 more)
1:06
SLEEP 2026: Phase 2 Study of Alixorexton in Narcolepsy Type 2
a month ago
by
Richard Bogan, MD, FCCP, FAASM(+1 more)
0:50
Adapting Exercise for Neurologic Conditions
a month ago
by
Mitzi Joi Williams, MD
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
The Expanding Role of Blood-Based Biomarkers in Alzheimer Disease
2
Advances in Fragile X Syndrome Therapeutics: Overviewing the Pipeline
3
The Role of Cerebrospinal Fluid in Personalized Alzheimer Disease Care: Betty Tijms, PhD
4
FDA Accepts BLA for Z-Rostudirsen in DMD, Sets January PDUFA Date
5